1. Home
  2. CARE vs IMMX Comparison

CARE vs IMMX Comparison

Compare CARE & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter Bankshares Inc.

CARE

Carter Bankshares Inc.

HOLD

Current Price

$32.26

Market Cap

723.5M

Sector

Finance

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$10.48

Market Cap

736.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARE
IMMX
Founded
1974
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.5M
736.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
CARE
IMMX
Price
$32.26
$10.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$25.00
$19.20
AVG Volume (30 Days)
440.6K
2.3M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
0.40%
N/A
EPS Growth
30.19
N/A
EPS
3.88
N/A
Revenue
$20,315,000.00
N/A
Revenue This Year
$12.50
N/A
Revenue Next Year
$11.82
N/A
P/E Ratio
$8.20
N/A
Revenue Growth
4.65
N/A
52 Week Low
$16.78
$1.94
52 Week High
$35.03
$12.14

Technical Indicators

Market Signals
Indicator
CARE
IMMX
Relative Strength Index (RSI) 56.76 54.73
Support Level $31.29 $7.99
Resistance Level $35.03 $10.61
Average True Range (ATR) 0.99 0.86
MACD -0.33 0.01
Stochastic Oscillator 25.53 35.83

Price Performance

Historical Comparison
CARE
IMMX

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: